TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CGEM

Cullinan Oncology LLC

Healthcare · Biotechnology

14.80$ -4.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Cullinan Oncology LLC (CGEM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -176 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CGEM
Line item 2012 2013 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025
– -0.7 -0.1 0.0 -0.2 -14 -21 -30 -43 -127 -134 -145 -176
– – – – – 0.0 0.1 0.1 0.1 0.1 0.3 0.3 0.3
– – – – – – 0.0 15 24 28 30 38 36
– 0.0 0.0 0.0 0.0 0.3 -0.4 15 24 28 – – –
– – – – – 0.3 0.1 6.9 -3.5 11 -0.3 -0.4 14
0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 1.1 0.2 0.0 0.0
– – – – – -0.3 -35 -5.4 -334 249 36 -136 180
– 1.0 1.0 1.0 1.0 0.0 -0.4 -0.2 271 -24 – – –
– 0.7 0.1 0.0 -0.8 – 0.2 0.2 0.2 -2.2 1.8 0.0 –
0.1 0.7 0.1 0.0 0.2 0.0 86 140 269 -26 41 266 1.1
– 0.0 0.0 0.0 0.0 -14 29 105 -108 96 -58 -15 5.3
– – – – – -14 -21 -30 -44 -128 -134 -145 -176

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?